Local immunotherapy (β-IFN) and systemic chemotherapy in primary glial tumors

A. Boiardi, A. Silvani, I. Milanesi, L. Munari, G. Broggi, M. Botturi

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Dosage and schedules for the treatment of malignant glial tumors using IFN (interferon) are still uncertain and controversial. In this study we give the preliminary results of treatment in 28 patients with glioblastoma multiforme (GBM). 6 patients were treated with local injection of β-IFN through an Ommaya reservoir; 4 patients with β-IFN followed by systemic chemotherapy (Cisplatin+Etoposide), and 18 patients with chemotherapy only. Two end points were evaluated: 1) Whether or not the patients responded to treatment. 2) Length of Time to Tumor Progression(TTP) after surgery. We found that IFN alone was ineffective. Results were improved when local immunotherapy was associated with systemic chemotherapy. New drugs and investigation of possible pharmacological synergism are needed.

Original languageEnglish
Pages (from-to)163-168
Number of pages6
JournalItalian Journal of Neurological Sciences
Volume12
Issue number2
DOIs
Publication statusPublished - Apr 1991

Fingerprint

Neuroglia
Immunotherapy
Interferons
Drug Therapy
Neoplasms
Etoposide
Glioblastoma
Cisplatin
Appointments and Schedules
Therapeutics
Pharmacology
Injections
Pharmaceutical Preparations

Keywords

  • chemotherapy
  • glial tumor
  • Interferon

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology

Cite this

Local immunotherapy (β-IFN) and systemic chemotherapy in primary glial tumors. / Boiardi, A.; Silvani, A.; Milanesi, I.; Munari, L.; Broggi, G.; Botturi, M.

In: Italian Journal of Neurological Sciences, Vol. 12, No. 2, 04.1991, p. 163-168.

Research output: Contribution to journalArticle

Boiardi, A. ; Silvani, A. ; Milanesi, I. ; Munari, L. ; Broggi, G. ; Botturi, M. / Local immunotherapy (β-IFN) and systemic chemotherapy in primary glial tumors. In: Italian Journal of Neurological Sciences. 1991 ; Vol. 12, No. 2. pp. 163-168.
@article{696601c5e6664b4691c631ee95dde0d9,
title = "Local immunotherapy (β-IFN) and systemic chemotherapy in primary glial tumors",
abstract = "Dosage and schedules for the treatment of malignant glial tumors using IFN (interferon) are still uncertain and controversial. In this study we give the preliminary results of treatment in 28 patients with glioblastoma multiforme (GBM). 6 patients were treated with local injection of β-IFN through an Ommaya reservoir; 4 patients with β-IFN followed by systemic chemotherapy (Cisplatin+Etoposide), and 18 patients with chemotherapy only. Two end points were evaluated: 1) Whether or not the patients responded to treatment. 2) Length of Time to Tumor Progression(TTP) after surgery. We found that IFN alone was ineffective. Results were improved when local immunotherapy was associated with systemic chemotherapy. New drugs and investigation of possible pharmacological synergism are needed.",
keywords = "chemotherapy, glial tumor, Interferon",
author = "A. Boiardi and A. Silvani and I. Milanesi and L. Munari and G. Broggi and M. Botturi",
year = "1991",
month = "4",
doi = "10.1007/BF02337028",
language = "English",
volume = "12",
pages = "163--168",
journal = "Italian Journal of Neurological Sciences",
issn = "0392-0461",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Local immunotherapy (β-IFN) and systemic chemotherapy in primary glial tumors

AU - Boiardi, A.

AU - Silvani, A.

AU - Milanesi, I.

AU - Munari, L.

AU - Broggi, G.

AU - Botturi, M.

PY - 1991/4

Y1 - 1991/4

N2 - Dosage and schedules for the treatment of malignant glial tumors using IFN (interferon) are still uncertain and controversial. In this study we give the preliminary results of treatment in 28 patients with glioblastoma multiforme (GBM). 6 patients were treated with local injection of β-IFN through an Ommaya reservoir; 4 patients with β-IFN followed by systemic chemotherapy (Cisplatin+Etoposide), and 18 patients with chemotherapy only. Two end points were evaluated: 1) Whether or not the patients responded to treatment. 2) Length of Time to Tumor Progression(TTP) after surgery. We found that IFN alone was ineffective. Results were improved when local immunotherapy was associated with systemic chemotherapy. New drugs and investigation of possible pharmacological synergism are needed.

AB - Dosage and schedules for the treatment of malignant glial tumors using IFN (interferon) are still uncertain and controversial. In this study we give the preliminary results of treatment in 28 patients with glioblastoma multiforme (GBM). 6 patients were treated with local injection of β-IFN through an Ommaya reservoir; 4 patients with β-IFN followed by systemic chemotherapy (Cisplatin+Etoposide), and 18 patients with chemotherapy only. Two end points were evaluated: 1) Whether or not the patients responded to treatment. 2) Length of Time to Tumor Progression(TTP) after surgery. We found that IFN alone was ineffective. Results were improved when local immunotherapy was associated with systemic chemotherapy. New drugs and investigation of possible pharmacological synergism are needed.

KW - chemotherapy

KW - glial tumor

KW - Interferon

UR - http://www.scopus.com/inward/record.url?scp=0025759004&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025759004&partnerID=8YFLogxK

U2 - 10.1007/BF02337028

DO - 10.1007/BF02337028

M3 - Article

VL - 12

SP - 163

EP - 168

JO - Italian Journal of Neurological Sciences

JF - Italian Journal of Neurological Sciences

SN - 0392-0461

IS - 2

ER -